QC
IBRX icon

Quent Capital’s ImmunityBio IBRX Stock Holding History

Quent Capital’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.25K Buy
815
+364
+81% +$2.49K ﹤0.01% 1242
2025
Q4 		$893 Buy
+451
New +$1.02K ﹤0.01% 1473
2024
Q2 		– Sell
-1,824
Closed -$9.79K – 1362
2024
Q1 		$9.79K Hold
1,824
– – ﹤0.01% 1023
2023
Q4 		$9.16K Sell
1,824
-5
-0.3% -$16 ﹤0.01% 988
2023
Q3 		$3.09K Buy
1,829
+1,392
+319% +$2.79K ﹤0.01% 1130
2023
Q2 		$1.22K Buy
437
+35
+9% +$99 ﹤0.01% 1228
2023
Q1 		$732 Buy
402
+89
+28% +$277 ﹤0.01% 1253
2022
Q4 		$1.59K Buy
+313
New +$1.72K ﹤0.01% 1177

Other funds holding IBRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return